SCHEMBL8075698

SCHEMBL8075698

CC(C)N1C(=O)C(NC(=O)Cc2cc(Cl)cc(Cl)c2)C(=O)N(C(C)C)c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.44
CCKBR P32239 3/20 0.42
CCR3 P51677 1/20 0.41
PSEN1 P49768 3/20 0.39
PSEN2 P49810 3/20 0.39
APH1B Q8WW43 3/20 0.39
NCSTN Q92542 3/20 0.39
APH1A Q96BI3 3/20 0.39
PSENEN Q9NZ42 3/20 0.39
SIGMAR1 Q99720 1/20 0.39
KCNQ2 O43526 3/20 0.38
EPHX2 P34913 1/20 0.38
XIAP P98170 1/20 0.38
LMNA P02545 1/20 0.38
GLA P06280 1/20 0.38
TSHR P16473 1/20 0.38
AVPR1A P37288 2/20 0.37
ACLY P53396 1/20 0.37
GRM7 Q14831 1/20 0.37
TACR1 P25103 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7044669 0.92 CCKBR (0.51) KCNH2CCKBRXIAP
SCHEMBL8075805 0.89 KCNH2 (0.56) KCNH2CCKBRCCR3PSEN1PSEN2
SCHEMBL7037818 0.85 KCNH2 (0.41) KCNH2CCR3PSEN1PSEN2APH1B
SCHEMBL8075696 0.83 SIGMAR1 (0.49) KCNH2SIGMAR1
SCHEMBL7854695 0.82 KCNH2 (0.41) KCNH2CCR3PSEN1PSEN2APH1B
SCHEMBL8075704 0.80 ALDH1A1 (0.52) KCNH2CCKBRSIGMAR1
SCHEMBL8761397 0.78 KCNH2 (0.69) KCNH2CCKBRPSEN1PSEN2APH1B
SCHEMBL8760298 0.78 KCNH2 (0.69) KCNH2CCKBRPSEN1PSEN2APH1B
SCHEMBL8761607 0.78 KCNH2 (0.69) KCNH2CCKBRPSEN1PSEN2APH1B
SCHEMBL8075665 0.77 KCNH2 (0.49) KCNH2CCKBRSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832075-B1 N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 2000-10-11 EP claimed
EP-0832075-A4 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 1998-10-07 EP claimed
EP-0832075-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES Merck & Co., Inc. (US) 1998-04-01 EP claimed
US-5691331-A N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides MERCK & CO., INC. (US) 1997-11-25 US claimed
WO-1996040655-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO., INC. (US) 1996-12-19 WO claimed
EP-0832075-B1 N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 2000-10-11 EP disclosed
EP-0832075-A4 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO INC (US) 1998-10-07 EP disclosed
EP-0832075-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES Merck & Co., Inc. (US) 1998-04-01 EP disclosed
US-5691331-A N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides MERCK & CO., INC. (US) 1997-11-25 US disclosed
WO-1996040655-A1 NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES MERCK & CO., INC. (US) 1996-12-19 WO disclosed